Literature DB >> 33320912

4-hexylresorcinol-induced protein expression changes in human umbilical cord vein endothelial cells as determined by immunoprecipitation high-performance liquid chromatography.

Yeon Sook Kim1, Dae Won Kim2, Seong-Gon Kim3, Suk Keun Lee4.   

Abstract

4-Hexylresorcinol (4HR) is used as a food preservative and an ingredient of toothpaste and cosmetics. The present study was performed using 233 antisera to determine the changes in protein expression induced by 4HR in human umbilical cord vein endothelial cells (HUVECs), and evaluated the 4HR-induced effects in comparison with previous results (Kim et al., 2019). Similar to RAW 264.7 cells, 4HR-treated HUVECs showed decreases in the expression of the proliferation-related proteins, cMyc/MAX/MAD network proteins, p53/RB and Wnt/β-catenin signaling, and they showed inactivation of DNA transcription and protein translation compared to the untreated controls. 4HR upregulated growth factors (TGF-β1, β2, β3, SMAD2/3, SMAD4, HGF-α, Met, IGF-1) and RAS signaling proteins (RAF-B, p38, p-p38, p-ERK-1, and Rab-1), and induced stronger expression of the cellular protection-, survival-, and differentiation-related proteins in HUVECs than in RAW 264.7 cells. 4HR suppressed NFkB signaling in a manner that suggests potential anti-inflammatory and wound healing effects by reducing M1 macrophage polarization and increasing M2 macrophage polarization in both cells. 4HR-treated HUVECs tended to increase the ER stress mediators by upregulating eIF2AK3, ATF4, ATF6, lysozyme, and LC3 and downregulating eIF2α and GADD153 (CHOP), resulting in PARP-1/AIF-mediated apoptosis. These results indicate that 4HR has similar effects on the protein expression of HUVECs and RAW 264.7 cells, but their protein expression levels differ according to cell types. The 4HR-treated cells showed global protein expression characteristic of anticancer and wound healing effects, which could be alleviated simultaneously by other proteins exerting opposite functions. These results suggest that although 4HR has similar effects on the global protein expression of HUVECs and RAW 264.7 cells, the 4HR-induced molecular interferences in those cells are complex enough to produce variable protein expression, leading different cell functions. Moreover, HUVECs have stronger wound healing potential to overcome the impact induced by 4HR than RAW 264.7 cells.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33320912      PMCID: PMC7737996          DOI: 10.1371/journal.pone.0243975

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  40 in total

1.  4-Hexylresorcinol as inhibitor of shrimp melanosis: efficacy and residues studies; evaluation of possible toxic effect in a human intestinal in vitro model (Caco-2); preliminary safety assessment.

Authors:  E Guandalini; A Ioppolo; A Mantovani; P Stacchini; C Giovannini
Journal:  Food Addit Contam       Date:  1998 Feb-Mar

2.  Inhibition of amyloid fibrillation of lysozyme by phenolic compounds involves quinoprotein formation.

Authors:  Shuang Feng; Xiu-Huan Song; Cheng-Ming Zeng
Journal:  FEBS Lett       Date:  2012-10-08       Impact factor: 4.124

3.  A dual role for poly(ADP-ribose) polymerase-1 during caspase-dependent apoptosis.

Authors:  Fengjiao Zhang; Serrine S Lau; Terrence J Monks
Journal:  Toxicol Sci       Date:  2012-04-20       Impact factor: 4.849

4.  2-deoxy-D-glucose augments photodynamic therapy induced mitochondrial caspase-independent apoptosis and energy-mediated autophagy.

Authors:  Xiaolan Feng; Yin Shi; Lifen Xie; Kun Zhang; Xiaobing Wang; Quanhong Liu; Pan Wang
Journal:  Lasers Surg Med       Date:  2018-09-17       Impact factor: 4.025

5.  NTP Toxicology and Carcinogenesis Studies of 4-Hexylresorcinol (CAS No. 136-77-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).

Authors: 
Journal:  Natl Toxicol Program Tech Rep Ser       Date:  1988-05

6.  Topical delivery of 4-hexylresorcinol promotes wound healing via tumor necrosis factor-α suppression.

Authors:  Janghoon Ahn; Seong-Gon Kim; Min-Keun Kim; Dae-Won Kim; Jang-Ha Lee; Hyun Seok; Je-Yong Choi
Journal:  Burns       Date:  2016-05-16       Impact factor: 2.744

7.  Detection and quantitation of cellularly derived amyloid beta peptides by immunoprecipitation-HPLC-MS.

Authors:  N J Clarke; A J Tomlinson; Y Ohyagi; S Younkin; S Naylor
Journal:  FEBS Lett       Date:  1998-07-03       Impact factor: 4.124

8.  Effects of resveratrol and 4-hexylresorcinol on hydrogen peroxide-induced oxidative DNA damage in human lymphocytes.

Authors:  Gow-Chin Yen; Pin-Der Duh; Chun-Wei Lin
Journal:  Free Radic Res       Date:  2003-05

Review 9.  Two different protein expression profiles of oral squamous cell carcinoma analyzed by immunoprecipitation high-performance liquid chromatography.

Authors:  Soung Min Kim; Dasul Jeong; Min Keun Kim; Sang Shin Lee; Suk Keun Lee
Journal:  World J Surg Oncol       Date:  2017-08-08       Impact factor: 2.754

10.  Reconstruction of partial maxillectomy defect with a buccal fat pad flap and application of 4-hexylresorcinol: a case report.

Authors:  Hyun Seok; Min-Keun Kim; Seong-Gon Kim
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2016-12-27
View more
  4 in total

1.  Effects of 4-hexylresorcinol administration on the submandibular glands in a growing rat model.

Authors:  Joo-Hyung Yoon; Dae-Won Kim; Suk Keun Lee; Seong-Gon Kim
Journal:  Head Face Med       Date:  2022-06-06       Impact factor: 2.246

2.  Pentoxifylline-induced protein expression change in RAW 264.7 cells as determined by immunoprecipitation-based high performance liquid chromatography.

Authors:  Mi Hyun Seo; Dae Won Kim; Yeon Sook Kim; Suk Keun Lee
Journal:  PLoS One       Date:  2022-03-25       Impact factor: 3.240

Review 3.  An Overview of Alkylresorcinols Biological Properties and Effects.

Authors:  Anastasia A Zabolotneva; Olga P Shatova; Anastasia A Sadova; Aleksandr V Shestopalov; Sergei A Roumiantsev
Journal:  J Nutr Metab       Date:  2022-01-05

Review 4.  4-Hexylresorcinol: pharmacologic chaperone and its application for wound healing.

Authors:  Seong-Gon Kim
Journal:  Maxillofac Plast Reconstr Surg       Date:  2022-02-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.